Syon Capital LLC Invests $13.23 Million in SPDR S&P China ETF (NYSEARCA:GXC)

Syon Capital LLC bought a new position in shares of SPDR S&P China ETF (NYSEARCA:GXC) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 194,171 shares of the company’s stock, valued at approximately $13,227,000. SPDR S&P China ETF makes up about 0.9% of Syon Capital LLC’s holdings, making the stock its 21st biggest position.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Upper Left Wealth Management LLC acquired a new position in SPDR S&P China ETF in the fourth quarter valued at about $239,000. Sharper & Granite LLC grew its position in SPDR S&P China ETF by 3.2% in the fourth quarter. Sharper & Granite LLC now owns 7,045 shares of the company’s stock valued at $480,000 after acquiring an additional 220 shares during the last quarter. EisnerAmper Wealth Management Corporate Benefits LLC bought a new position in SPDR S&P China ETF in the fourth quarter valued at about $1,061,000. Simplicity Solutions LLC grew its position in SPDR S&P China ETF by 5.3% in the third quarter. Simplicity Solutions LLC now owns 19,026 shares of the company’s stock valued at $1,361,000 after acquiring an additional 954 shares during the last quarter. Finally, Prism Advisors Inc. bought a new position in SPDR S&P China ETF in the fourth quarter valued at about $2,019,000.

SPDR S&P China ETF Trading Up 1.9 %

SPDR S&P China ETF stock traded up $1.28 during midday trading on Friday, reaching $69.44. The company’s stock had a trading volume of 22,272 shares, compared to its average volume of 156,118. SPDR S&P China ETF has a 52 week low of $59.45 and a 52 week high of $81.72. The business has a 50-day moving average price of $65.89 and a 200-day moving average price of $66.79. The stock has a market cap of $506.91 million, a PE ratio of 8.99 and a beta of 0.86.

SPDR S&P China ETF Profile

SPDR S&P China ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P/Citigroup BMI China Index (the Index). The Index is a market capitalization-weighted index that defines and measures the investable universe of publicly traded companies domiciled in China, but legally available to foreign investors.